Home saliva tests could map Alzheimer's genetic risk across france
NCT ID NCT07679906
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study aims to enroll 50,000 adults aged 45 and older in France to test for a gene called APOE, which is linked to Alzheimer's risk. Participants provide a saliva sample at home and complete online questionnaires. The goal is to build a large registry of genetic and health data to better understand who is at risk and to prepare for future prevention studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could create a national registry to identify people at high genetic risk for Alzheimer's, enabling future prevention trials and personalized strategies.
What could go wrong
This is an observational study, not a treatment trial. It will not directly prevent or treat Alzheimer's, and its success depends on large-scale participation and long-term follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
FIRALIS SA - Centre de Prélèvements Biologiques
RECRUITINGHuningue, 68330, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••